TUCSON, Ariz., Jan. 9, 2025 /PRNewswire/ -- SynCardia Systems, LLC ("SynCardia", or the "Company"), a Picard Medical, Inc. company, and the global leader in total artificial heart technology, is pleased to announce that the China National Intellectual Property Administration ("CNIPA") has...
Hence then, the article about syncardia systems receives decision to grant first patent in china for the emperor next generation total artificial heart was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( SynCardia Systems Receives Decision to Grant First Patent in China for the Emperor Next-Generation Total Artificial Heart )
Also on site :
- Emerson and Strategic Biofuels to Deliver Renewable Carbon-Neutral Power to Louisiana
- daydream beschafft 15 Millionen US-Dollar in der Serie A, um die weltweit beste AI-native Agentur für SEO aufzubauen
- 40% of Russia's Baltic Oil Export Capacity Offline as Gasoline Ban Widens